Our drug discovery system seems broken: Richard Owens in the Financial Post
Now more than ever, we should want drug companies to be able to charge high prices, writes Richard Owens in the Financial Post. Below...
Governments should not have a monopoly over drug development: Richard Owens and Sean Speer for Inside Policy
The World Health Organization (WHO) is exploring possibly sweeping changes to intellectual property policies in the name of cheaper drug prices, write Richard...
